on Santen Pharmaceutical Co., Ltd. (ETR:SZD)
Santen Aligns with Global Summit for Eye Health as Key Partner
Santen Pharmaceutical Co., Ltd. has announced its partnership with the inaugural Global Summit for Eye Health as a High Impact Partner. The Summit, organized by the International Agency for the Prevention of Blindness (IAPB), in collaboration with the World Health Organization (WHO), will convene in Antigua & Barbuda on November 2, 2026. The event aims to address critical gaps in global eye care by launching the Global Eye Health Compact, a framework designed to foster measurable commitments from governments and organizations worldwide.
Santen will unveil its strategic commitments to enhance global eye health, focusing on access to care and policy advancement. With over a billion people affected by preventable vision impairments globally, this initiative underscores Santen's ongoing dedication to eye health, in collaboration with various stakeholders including healthcare professionals, governments, and patient organizations. Santen's leadership aims to cultivate significant improvements in eye care delivery systems worldwide.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Santen Pharmaceutical Co., Ltd. news